The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
3-Methoxy-N-[3-(2-methyl-2H-pyrazol-3-yl)-4-(2-morpholin-4-yl-ethoxy)-phenyl]-benzamide ID: ALA1084617
Cas Number: 887936-68-7
PubChem CID: 11604525
Product Number: T726144, Order Now?
Max Phase: Phase
Molecular Formula: C24H28N4O4
Molecular Weight: 436.51
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Synonyms: Apd791 | Temanogrel | APD-791 | APD791 | TEMANOGREL|887936-68-7|APD791|Temanogrel [USAN:INN]|UNII-F42Z27575A|APD 791|APD-791|Benzamide, 3-methoxy-N-[3-(1-methyl-1H-pyrazol-5-yl)-4-[2-(4-morpholinyl)ethoxy]phenyl]-|F42Z27575A|CHEMBL1084617|3-Methoxy-N-(3-(1-methyl-1H-pyrazol-5-yl)-4-(2-(morpholin-4- yl)ethoxy)phenyl)benzamide|3-Methoxy-N-(3-(2-methyl-2H-pyrazol-3-yl)-4-(2-morpholin-4-yl-ethoxy)-phenyl)- benzamide|3-methoxy-N-[3-(2-methylpyrazol-3-yl)-4-(2-morpholin-4-ylethoxy)phenyl]benzamide|Ben Show More⌵
Synonyms from Alternative Forms(3): Temanogrel hcl | APD791 | Temanogrel hydrochloride
Canonical SMILES: COc1cccc(C(=O)Nc2ccc(OCCN3CCOCC3)c(-c3ccnn3C)c2)c1
Standard InChI: InChI=1S/C24H28N4O4/c1-27-22(8-9-25-27)21-17-19(26-24(29)18-4-3-5-20(16-18)30-2)6-7-23(21)32-15-12-28-10-13-31-14-11-28/h3-9,16-17H,10-15H2,1-2H3,(H,26,29)
Standard InChI Key: ZEOQUKRCASTCFR-UHFFFAOYSA-N
Molfile:
RDKit 2D
32 35 0 0 0 0 0 0 0 0999 V2000
-11.2173 0.3992 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-12.0019 0.1443 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-13.3997 0.4414 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-12.6150 0.6963 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-12.1735 -0.6627 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-12.9581 -0.9177 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-13.5712 -0.3656 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-13.1296 -1.7246 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-12.5165 -2.2767 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-13.9142 -1.9796 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-14.0858 -2.7865 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-14.8704 -3.0415 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-13.4727 -3.3386 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-13.6442 -4.1455 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-14.4288 -4.4005 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-15.0419 -3.8484 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-15.8265 -4.1034 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-17.1614 -4.1034 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-16.4940 -3.6185 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-16.0815 -4.8880 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-16.9065 -4.8880 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-16.4940 -2.7935 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-14.6004 -5.2075 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-15.3850 -5.4624 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-15.5565 -6.2694 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-16.3411 -6.5243 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-17.7388 -6.2272 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-16.9542 -5.9723 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-16.5127 -7.3313 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-17.2973 -7.5862 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-17.9104 -7.0342 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-11.0458 1.2062 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
4 2 2 0
2 5 1 0
3 4 1 0
3 7 2 0
5 6 2 0
6 7 1 0
6 8 1 0
8 9 2 0
8 10 1 0
10 11 1 0
12 11 2 0
11 13 1 0
12 16 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 17 1 0
19 17 1 0
17 20 2 0
18 19 1 0
18 21 2 0
20 21 1 0
19 22 1 0
15 23 1 0
23 24 1 0
24 25 1 0
25 26 1 0
28 26 1 0
26 29 1 0
27 28 1 0
27 31 1 0
29 30 1 0
30 31 1 0
1 32 1 0
M END
Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: YesAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 436.51Molecular Weight (Monoisotopic): 436.2111AlogP: 3.06#Rotatable Bonds: 8Polar Surface Area: 77.85Molecular Species: NEUTRALHBA: 7HBD: 1#RO5 Violations: ┄HBA (Lipinski): 8HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 6.76CX LogP: 2.55CX LogD: 2.46Aromatic Rings: 3Heavy Atoms: 32QED Weighted: 0.58Np Likeness Score: -1.86
References 1. Xiong Y, Teegarden BR, Choi JS, Strah-Pleynet S, Decaire M, Jayakumar H, Dosa PI, Casper MD, Pham L, Feichtinger K, Ullman B, Adams J, Yuskin D, Frazer J, Morgan M, Sadeque A, Chen W, Webb RR, Connolly DT, Semple G, Al-Shamma H.. (2010) Discovery and structure-activity relationship of 3-methoxy-N-(3-(1-methyl-1H-pyrazol-5-yl)-4-(2-morpholinoethoxy)phenyl)benzamide (APD791): a highly selective 5-hydroxytryptamine2A receptor inverse agonist for the treatment of arterial thrombosis., 53 (11): [PMID:20455563 ] [10.1021/jm100044a ] 2. USP Dictionary of USAN and International Names (2010 edition) and USAN registrations 2007-date, 3. Unpublished dataset,